Additionally, the Phase 1 clinical trial evaluating QTX3034, an oral G12D-preferring multi-KRAS inhibitor, as a monotherapy and in combination with cetuximab, continues to enroll patients, and data is ...
For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious ...
In a significant advancement for cancer research, a team of scientists from Max Planck Institute for Biology Tübingen, ...
News Medical on MSN8h
Scientists discover new target for treating aggressive brain cancerA study co-led by UCLA scientists has found targeting a protein called endocan and its related signaling pathway could be a promising new approach for treating glioblastoma, an aggressive and lethal ...
Rights Jul 11, 2023 Jul 11, 2023 Feb 25, 2023 Rights ratio: 38 share for every 29 held at a price of Rs 1.0 Rights Aug 08, 2022 Aug 10, 2022 Apr 27, 2022 Rights ratio: 35 share for every 13 held at a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback